Font Size: a A A
Keyword [large B-cell lymphoma]
Result: 121 - 140 | Page: 7 of 10
121. The Significance Of CD44ICD In Difuse Large B-cell Lymphoma Cell Line SUDHL2and The Preliminary Study On The Mechanism
122. Study On Clincopathological Features And Microvessel Density Of Human Primary Central Nervous System Diffuse Large B Cell Lymphoma
123. Research On The Prognostic Factors Of Cases With Opposite Results According To Immunophenotypic Classifications In Diffuse Large B-cell Lymphoma
124. Expression And Clinical Significance Of CD40in Diffuse Large B-cell Lymphoma
125. Significance Of MicroRNA-146b-5p In Difeuse Large B-cell Lymphoma And Its Relation To Risk Assessment
126. The Investigation Of MYC Gene Aberration In Diffuse Large B-cell Lymphomas
127. Clinic Analysis Of A Case Of Primary Diffuse Large B Cell Lymphoma Of Bone With Hemophagocytic Symdrome
128. A Case Report Of Diffuse Large B-cell Lymphoma With Hemophagocytic Syndrome And Literature Review
129. A Case Report Of Post-transplant Lymphoproliferative Disorder And Literature Review
130. Case Analysis Of Elderly Patients With Refractory Diffuse Large B-cell Lymphoma And Literature Review
131. Analysis Of The Prognosis Of159Cases With Diffuse Large B Cell Lymphoma(DLBCL)
132. Study On Rituximab Plus Chemotherpay Onpatients With Diffuse Large B-cell Lymphoma
133. Relationship Between Lymphopenia Following The Completion Of R-CHOP Chemotherapy And Relapse In Patients With Diffuse Large B Cell
134. The Expression Of FOXP3and Its Prognosis In Diffuse Large B Cell Lymphoma
135. HENT1、NF-κB Expression In Diffuse Large B Cell Lymphoma And Its Significance
136. The Correlation Analysis Of Prognostic And Immunophenotype Between Uygur And Han Race In Diffuse Large B-cell Lymphoma
137. Correlation Between The Clinical Features And Immunological Subtypes Of Diffuse Large B-cell Lymphoma In Uyghur And Han Patients
138. Clinical Significance Of Absolute Lymphocyte Count In Extranodal Diffuse Large B Cell Lymphoma
139. Combined Measurement Of Immunophenotype And International Staging System In Multiple Myeloma Defines Patients With Good Or Poor Prognosis
140. Clinical Analysis Of49Patients With Primary Mediastinal Large B Cell Lymphoma
  <<First  <Prev  Next>  Last>>  Jump to